FARALLON CAPITAL MANAGEMENT LLC - POINT BIOPHARMA GLOBAL INC ownership

POINT BIOPHARMA GLOBAL INC's ticker is PNT and the CUSIP is 730541109. A total of 84 filers reported holding POINT BIOPHARMA GLOBAL INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
FARALLON CAPITAL MANAGEMENT LLC ownership history of POINT BIOPHARMA GLOBAL INC
ValueSharesWeighting
Q1 2022$4,992,000
-47.8%
626,322
-63.3%
0.02%
-50.0%
Q4 2021$9,555,000
-45.7%
1,706,329
-25.5%
0.05%
-41.5%
Q3 2021$17,610,0002,290,0000.08%
Other shareholders
POINT BIOPHARMA GLOBAL INC shareholders Q2 2022
NameSharesValueWeighting ↓
Fairmount Funds Management LLC 2,312,523$18,431,0004.36%
GREAT POINT PARTNERS LLC 2,060,000$16,418,0003.97%
RA Capital Management 9,003,018$71,754,0001.57%
JOHNSON & JOHNSON 1,000,000$7,970,0001.51%
BVF INC/IL 3,367,826$26,842,0001.07%
Boxer Capital, LLC 2,500,000$19,925,0001.02%
Sio Capital Management, LLC 377,684$3,010,0001.00%
SUVRETTA CAPITAL MANAGEMENT, LLC 3,014,408$24,025,0000.73%
SILVERARC CAPITAL MANAGEMENT, LLC 204,679$1,631,0000.68%
Atom Investors LP 60,103$479,0000.22%
View complete list of POINT BIOPHARMA GLOBAL INC shareholders